posts browsing tag

Sequencing

– The largest number of regions and races included in any Asian reference panel – Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea–The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo) (KOSDAQ: 038290) announced on Dec 4 that …

Continue reading

SEOUL, South Korea–The precision medicine and biotechnology company, Macrogen (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), announced on December 20 that its NGS clinical laboratories in Seoul headquarters and Bundang Precision Medicine Center had officially received CLIA (Clinical Laboratory Improvement Amendments) accreditation, as the first in …

Continue reading

Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest – Macrogen establishes ‘Macrogen Asia Pacific’, a Subsidiary in Singapore – Targeting Southeast Asian market…Focus on large-scale genome analysis project SEOUL, South Korea–Macrogen, Inc. (President Ji-young Moon, www.macrogen.com) (KOSDAQ …

Continue reading

The unique genetic diversity that is prevalent in South, North, and East Asia provides a valuable source for clinical insights that will be able to enhance the understanding of disease biology. In order to help accelerate population specific precision medicine, Macrogen got involved with Genome Asia 100K in 2016, and …

Continue reading

  What does it mean to map the human genome? Humans may be 99.9 per cent similar to one another, yet the miniscule remaining percentage spells all the difference – making one drug effective for one patient and life-threatening for another. Having a map of one’s genome means …

Continue reading